πŸ‡ΊπŸ‡Έ FDA
Patent

US 10077250

Antifungal compound process

granted A61PA61P31/04

Quick answer

US patent 10077250 (Antifungal compound process) held by Tlie United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Sep 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Tlie United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Sep 18 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61P, A61P31/04